The Forecast Just Changed on Albireo Pharma Inc. (NASDAQ:ALBO)

The Forecast Just Changed on Albireo Pharma Inc. (NASDAQ:ALBO)

SHARE

The Albireo Pharma Inc. (ALBO) shares are trading at higher $29.92 and the avg recommendation for the stock is Strong Buy.

To add more color to this target, the company’s high over the last year is $32.49 and the low is $11.26. Over the last 52 weeks, ALBO is down -7.91% while the S&P 500 is up 1.07%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, ALBO reported a profit of $31.1 million. Albireo Pharma Inc. also saw revenues increase to $1.55 million. In addition, ALBO has free cash flow of -$23.8 million as of 03-2020 The company’s EBITDA came in at -$27.47 million which compares well with its peers.

ALBO Return on Equity (ROE) is -72.80%, and its Return on Assets is -44.30%. All told, it is clear that, ALBO needs to be on your watchlist.

Find out when ALBO reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ALBO has a short ratio of 3.17 and outstanding shares of 14.13M.

Company Outlook

ALBO has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 77920.0 and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -5.89. Albireo Pharma Inc. ALBO also noted assets of $182.11 million at the end of the last quarter. Investors should also keep an eye on sector updates as ALBO has historically followed its peers on positive news.

All told, Albireo Pharma Inc. ALBO has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ALBO represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Albireo Pharma Inc. ALBO is now commanding a market cap of 423.37M and a float of 11.62M. ALBO is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ALBO stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in ALBO, either long or short, and we have not been compensated for this article.